Barry M. Rosenfeld is a distinguished legal executive with extensive expertise in the biopharmaceutical and healthcare industries, known for his unwavering integrity, strategic foresight, and ability to navigate complex regulatory landscapes. With a career spanning transformative roles at Oyster Point Pharma, Novartis Group Companies, and his consultancy at B. Rosenfeld LLC, Barry has driven impactful legal strategies across corporate governance, intellectual property, product development, and M&A transactions. His deep knowledge and effective communication skills have enabled him to align legal frameworks with business objectives, guide cross-functional teams, and deliver solutions that balance risk and innovation, cementing his reputation as a trusted leader in high-stakes environments.